Literature DB >> 12456408

The detection of changes in heparin activity in the rabbit: a comparison of anti-xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time.

Vance G Nielsen1.   

Abstract

UNLABELLED: Thrombelastography (TEG) has been used to detect both exogenous and endogenous circulating heparin activity in clinical and laboratory settings. Thus, in this study I sought to compare the sensitivity of TEG, activated partial thromboplastin time (aPTT), and activated coagulation time (ACT) values with changes in anti-Xa activity after small-dose heparin administration in rabbits. Conscious rabbits (n = 11) had blood obtained from ear arteries for hematological analyses after the administration of 0, 10, 20, and 30 U/kg of IV heparin. Anti-Xa activities after the administration of 0, 10, 20, and 30 U/kg of heparin were, respectively, 38 +/- 9 mU/mL, 74 +/- 15 mU/mL, 105 +/- 14 mU/mL, and 134 +/- 17 mU/mL; all values were significantly different from each other. TEG variables (R and alpha) significantly (P < 0.05) changed between 0, 10, and 20 U/kg heparin doses, but a difference between 20 and 30 U/kg could not be discerned secondary to loss of a detectable clot. The aPTT was significantly (P < 0.05) different between 0, 20, and 30 U/kg doses. ACT values were significantly different between the 0 U/kg heparin dose and all other doses; however, there were no significant differences between the 10, 20, and 30 U/kg heparin doses. Changes in anti-Xa activity were significantly linearly related to R (r = 0.81, P < 0.0001), alpha (r = -0.85, P < 0.0001), aPTT (r = 0.74, P < 0.0001), and ACT (r = 0.41, P = 0.005). In this model of small-dose heparin administration, TEG variables were more sensitive to changes in heparin activity than aPTT and ACT. IMPLICATIONS: Changes in thrombelastography (TEG) variables more sensitively reflect changes in circulating heparin activity than activated partial thromboplastin time (aPTT) and activated coagulation time (ACT) after small-dose heparin administration in rabbits. Thus, TEG may be more helpful than aPTT and ACT in the detection of heparin in both laboratory and clinical settings wherein heparin may play a role in coagulopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456408     DOI: 10.1097/00000539-200212000-00008

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Ionic liquid-derived blood-compatible composite membranes for kidney dialysis.

Authors:  Saravanababu Murugesan; Shaker Mousa; Aravind Vijayaraghavan; Pulickel M Ajayan; Robert J Linhardt
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2006-11       Impact factor: 3.368

2.  Blood compatible carbon nanotubes--nano-based neoproteoglycans.

Authors:  Saravanababu Murugesan; Tae-Joon Park; Hoichang Yang; Shaker Mousa; Robert J Linhardt
Journal:  Langmuir       Date:  2006-04-11       Impact factor: 3.882

3.  Heparin-induced effects of prothrombin complex concentrates in thromboelastometry.

Authors:  Gisela Scharbert; Ulrich Thaler; Christoph Weilnböck; Léonore Wetzel; Sibylle Kozek-Langenecker
Journal:  Wien Klin Wochenschr       Date:  2012-05-11       Impact factor: 1.704

4.  Inactivation of heparin by cationically modified chitosan.

Authors:  Barbara Lorkowska-Zawicka; Kamil Kamiński; Justyna Ciejka; Krzysztof Szczubiałka; Magdalena Białas; Krzysztof Okoń; Dariusz Adamek; Maria Nowakowska; Jacek Jawień; Rafał Olszanecki; Ryszard Korbut
Journal:  Mar Drugs       Date:  2014-06-30       Impact factor: 5.118

5.  Influence of alcohol consumption on blood coagulation in rotational thromboelastometry (ROTEM): an in-vivo study.

Authors:  Hendrik Eismann; Lion Sieg; Hala Ahmed; Joerg Teske; Patrick Behrendt; Lars Friedrich; Carsten Schumacher; Kai Johanning
Journal:  Korean J Anesthesiol       Date:  2020-04-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.